You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post Marketing Surveillance

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

CTAG Dissection/Trauma Post Marketing Surveillance Japan

Completed
  • Thoracic Aortic Aneurysm
  • +2 more
  • Conformable GORE® TAG® Thoracic Endoprosthesis
  • (no location specified)
Jan 11, 2023

Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia

Not yet recruiting
  • Myelodysplastic Syndrome
  • Beta Thalassemia
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Assess Safety of Ozanimod in Moderate to Severe Active UC in

Not yet recruiting
  • Ulcerative Colitis
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
  • Oral azacitidine
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Besponsa Post Marketing Surveillance Study

Active, not recruiting
  • Hematologic Maligmancy
  • Inotuzumab ozogamicin
  • Seoul, Korea, Republic of
    Pfizer
Oct 10, 2022

Saphir Stem in Primary Hip Surgery

Recruiting
  • Arthropathy of Hip
  • hip arthroplasty with prosthesis
  • Toulouse, France
    Hopital Ducuing
Dec 12, 2022

Korean Regulatory Post Marketing Surveillance for Somavert

Not yet recruiting
  • Acromegaly
  • (no location specified)
Jul 18, 2022

Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

Not yet recruiting
  • Metastatic ALK+ Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Pfizer
Jan 24, 2023

Assess Deucravacitinib Post-marketing Surveillance in Psoriasis

Not yet recruiting
  • Psoriasis
    • Tosima-ku, Tokyo, Japan
      Local Institution
    Nov 22, 2022

    Juvenile Idiopathic Arthritis

    Not yet recruiting
    • Psoriatic Arthritis, Juvenile
    • Polyarticular Juvenile Idiopathic Arthritis
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Feb 22, 2023

    Xeljanz (Registered) in Ulcerative Colitis Patients

    Completed
    • Ulcerative Colitis
    • Non-intervention
    • Seoul, Korea, Republic of
      Pfizer
    Nov 16, 2022

    Korean Post-marketing Surveillance for Xeljanz XR

    Recruiting
    • Active Moderate to Severe Rheumatoid Arthritis
    • Active Ankylosing Spondylitis
    • Tofacitinib XR
    • Seoul, Korea, Republic of
      Pfizer
    Oct 10, 2022

    Korea Post Marketing Surveillance (PMS) Study of Vizimpro

    Enrolling by invitation
    • Lung Neoplasms
    • Seoul, Korea, Republic of
      Pfizer
    Sep 21, 2022

    Safety Issues Trial in Surabaya (Diphtheria Antitoxin)

    Completed
    • Safety Issues
    • Diphtheria Antitoxin
    • Surabaya, East Java, Indonesia
      RSUD Dr. Soetomo
    Sep 19, 2023

    Korea Post Marketing Surveillance (PMS) Study of Talzenna®

    Not yet recruiting
    • Breast Neoplasms
    • (no location specified)
    Aug 1, 2022

    Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases

    Active, not recruiting
    • Lung Diseases, Interstitial
    • Tokyo, Japan
      Nippon Boehringer Ingelheim Co., Ltd.
    Jan 9, 2023

    Data of Intravitreal Aflibercept Injection in Patients of Wet

    Completed
    • Wet Age-related Macular Degeneration
    • Aflibercept (Eylea, BAY86-5321)
    • Multiple Locations, India
      Many Locations
    Feb 2, 2023

    Vyndamax® Capsules for Treatment of Transthyretin Amyloid

    Recruiting
    • ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
    • Vyndamax (tafamidis 61mg)
    • Seoul, Korea, Republic of
      Pfizer
    Aug 16, 2022

    A Post Marketing Surveillance on Piqray in Korea

    Recruiting
    • Breast Cancer
    • Piqray
    • Deogyang Gu Goyang Si, Gyeonggi Do, Korea, Republic of
    • +4 more
    Jan 16, 2023

    Ngenla® Pre-filled Pen Injection for Treatment of Pediatric

    Not yet recruiting
    • Pediatric Growth Hormone Deficiency
    • (no location specified)
    Aug 19, 2022

    Xolair® for Chronic Rhinosinusitis With Nasal Polyps

    Recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • Xolair
    • Bundang Gu, Gyeonggi Do, Korea, Republic of
      Novartis Investigative Site
    Jan 19, 2023

    Niraparib in Treatment of Adult Approved Indications in South

    Recruiting
    • Ovarian Neoplasms
      • Busan, Korea, Republic of
        Inje University Haeundae Paik Hospital
      Oct 19, 2022

      (PMS) of JARDIANCE in Chronic Heart Failure (CHF)

      Recruiting
      • Heart Failure
      • Tokyo, Japan
        Nippon Boehringer Ingelheim Co., Ltd.
      Aug 10, 2022

      Chronic Kidney Diseases, Anemia of Chronic Kidney Disease Trial (Desidustat)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Anemia of Chronic Kidney Disease
      • (no location specified)
      Aug 23, 2022